CRISM Therapeutics Corporation

8.50pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:CRTXHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 10Y CAGR (4.80%)
Div yield —
ROE (122.70%)
Biotechnology
Beta (5Y) 0.56
PE TTM —
TSR TTM (27.66%)
Mkt cap £6.731M
ROIC (77.08%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
11p
28.63%
(14.81%)
Buy 2|2|1|5|0
4Q25
1Q26
2Q26
3Q26
Earnings per share£
0.11
0.12
0.12
0.12
35.92%
36.79%
31.36%
20.11%
Revenue£M
0.607
0.591
0.613
0.639
3.42%
1.85%
0.54%
6.96%
Peers (US$9.056M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.813
0.247
0.218
EBIT/Intx
6.828
0.479
0.533
Own earn%
(11.69)
27.45
11.24
Sh yield%
28.71
36.67
38.97
Owners
Insiders/Inst%
6.79
40.48
Short interest%
2.33
SBC / revenue%
2.28
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
21–27
$1 testx
−0.3
Incr. ROIC%
0